Information on the Total Number of Voting Rights
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital...
Source: globenewswire.com
Oxurion Nv News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oxurion Nv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oxurion Nv Today - Breaking & Trending Today
Information on the Total Number of Voting Rights
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital...
Source: globenewswire.com
Oxurion Receives Transparency Notifications from Atlas
Regulated Information Leuven, BELGIUM, Boston, MA, US – October 20, 2023 – 8.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Source: globenewswire.com
Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program
EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial Leuven, BELGIUM, Boston, MA, US – September 18, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 5 of funding under the Subscription Agreement with Atlas Special Opportunities LLC (“Atlas”). On Septe
Source: yahoo.com
Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program
EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial Leuven, BELGIUM, Boston, MA, US – September 18, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 5 of funding under the Subscription Agreement with Atlas Special Opportunities LLC (“Atlas”). On Septe
Source: yahoo.com